CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ | |
Journals - Article | |
Česky / Czech version | Vnitř. Lék., 47, 2001, No. 9, p. 627-633 |
New Agents in the Treatment with Peroral Antidiabetics Pospíšilová Y.: Interní hematoonkologická klinika FN Brno, pracoviště Bohunice, přednosta prof. MUDr. J. Vorlíček, CSc. |
|
Summary: In this article two new peroral antidiabetics are introduced. The first is repaglinide, a prandial
glucose regulator. The second is rosiglitazone, a member of the thiazolidinediones family, which
improves the sensitivity of tissues to insulin and reduces insulin resistance.
|
|
Order this issue
|
BACK TO CONTENTS | ||
| HOME PAGE | CODE PAGE | CZECH VERSION | |
© 1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ |
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o. |
WEBMASTER |